BAM
Byrne Asset Management’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-29,600
| Closed | -$750K | – | 59 |
|
|
2025
Q1 | $750K | Buy |
29,600
+738
| +3% | +$18.7K | 0.55% | 53 |
|
|
2024
Q4 | $766K | Sell |
28,862
-1,638
| -5% | -$43.5K | 0.54% | 56 |
|
|
2024
Q3 | $883K | Sell |
30,500
-2,165
| -7% | -$62.7K | 0.6% | 54 |
|
|
2024
Q2 | $908K | Buy |
+32,665
| New | +$908K | 0.65% | 49 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 50 |
|
|
2023
Q4 | – | Sell |
-39,413
| Closed | -$1.31M | – | 44 |
|
|
2023
Q3 | $1.31M | Sell |
39,413
-1,390
| -3% | -$46.1K | 1.08% | 25 |
|
|
2023
Q2 | $1.5M | Buy |
40,803
+750
| +2% | +$27.5K | 0.97% | 19 |
|
|
2023
Q1 | $1.63M | Sell |
40,053
-635
| -2% | -$25.9K | 1.17% | 13 |
|
|
2022
Q4 | $2.08M | Sell |
40,688
-1,535
| -4% | -$78.7K | 1.51% | 10 |
|
|
2022
Q3 | $1.85M | Buy |
42,223
+170
| +0.4% | +$7.44K | 1.42% | 11 |
|
|
2022
Q2 | $2.21M | Sell |
42,053
-150
| -0.4% | -$7.87K | 1.63% | 13 |
|
|
2022
Q1 | $2.19M | Buy |
42,203
+1,675
| +4% | +$86.7K | 1.36% | 18 |
|
|
2021
Q4 | $2.39M | Buy |
+40,528
| New | +$2.39M | 1.55% | 13 |
|